About

Breathomix is advancing the BreathBase® Solution for disease detection, aiming to make breath analysis as routine in clinical practice as blood testing. Our vision is to set a new standard in non-invasive diagnostics, driving early detection and precision medicine.

Breath Analysis for Disease

Breathomics, the study of exhaled breath, identifies breath as a rich source of biological information, much like blood or urine. In addition to familiar gases like oxygen and carbon dioxide, exhaled breath contains thousands of volatile organic compounds (VOCs) at trace levels. These VOCs hold valuable insights into our health and serve as the foundation of Breathomix’s diagnostic approach.

Our mission: Making breath analysis as routine in clinical practice as blood testing

Our mission envisions a future where breath analysis becomes a standard, accessible diagnostic tool in healthcare. Just as blood tests are essential for early diagnosis, disease monitoring, and personalized treatment planning, we aim to establish breath analysis as a non-invasive, reliable option that delivers valuable insights across various diseases. By integrating breath analysis into routine clinical workflows, we can:

Enhance Early Detection: Breath analysis can serve as a frontline tool for identifying conditions like cancer, respiratory diseases, and infections in their earliest stages.
Support Precision Medicine: Routine breath analyses enable personalized treatment approaches based on individual breath profiles.
Increase Accessibility: Bringing breath analysis to hospitals, clinics, and even home care enables more people to benefit from timely and accurate diagnostic insights.

Our Vision: Setting the standard in breath analysis for early detection and precision medicine – accessible from hospitals to homes

Our vision reflects our commitment to making breath diagnostics an integral part of healthcare at every level. By establishing the BreathBase® Solution as a gold standard in breath analysis, we aim to empower clinicians and patients with powerful, non-invasive diagnostic tools for earlier detection and personalized care. With this vision, Breathomix is pioneering a future where breath analysis by eNose technology becomes a trusted component of modern healthcare.

Breath Analysis: a new diagnostic modality

Breath analysis represents a groundbreaking diagnostic approach, aiming to identify novel, non-invasive composite biomarkers in exhaled breath that can be used at the point-of-care. With our award-winning SpiroNose®, we capture high-quality breath measurements that reflect the complete mixture of volatile organic compounds (VOCs) in each breath. Using the advanced BreathBase® platform, these VOC profiles are analyzed in real-time, enabling the development of diagnostic models to detect validated disease biomarkers. Our goal is to make breath analysis an accessible, reliable tool for early detection and precision medicine.

SpiroNose®: The process starts with a simple breath maneuver into the SpiroNose®. The device’s sensors instantly detect the full mixture of VOCs in the exhaled breath.

BreathBase® Platform: The captured sensor data is transmitted in real-time to this online analysis platform, where it is processed into a comprehensive breath profile.

BreathBase® Data: The breath profile is compared with a comprehensive reference database of breath samples and clinical data, carefully compiled based on rigorous scientific research.

Report: Within seconds, the BreathBase® Solution generates a diagnostic report, providing insights into potential conditions like ILD, PPF, COPD, and various cancers.